KYNTHEUM 210 mg, solution for injection in a pre-filled syringe 2 syringes of 1.5 ml
Active ingredients: Brodalumab
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 syringes of 1.5 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KYNTHEUM 210 mg, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 2 seringues préremplies en verre de 1,5 ml
- Marketing authorisation holder
- LEO PHARMA A/S (DANEMARK)
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Psoriasis en plaque (qui est une maladie inflammatoire de la peau), chez l'adulte, dans les cas où celui-ci répond à un certain nombre de critères de gravité. ; JOURNAL OFFICIEL ; 02/10/18
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Oct 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65620419CIP73011728CIP133400930117286Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BRODALUMABsolution | 210 mg · 1,5 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.